Alcon Sues Apotex, Sandoz Over Eyedrops Patents
Alcon lodged both lawsuits Monday in the U.S. District Court for the Southern District of Indiana after learning that Apotex and Sandoz had sought approval from the U.S. Food and Drug Administration to make and market generic versions of Alcon's allergy-relieving eyedrops.
According to the complaint against Apotex, Alcon learned that Apotex had filed an abbreviated...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login